Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Innate Immune Training in Adults >50
NCT02953327Phase 4Completed
- Sponsor
- Bandim Health Project
- Start
- Feb 2017
- Primary completion
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of bcg vaccine in Infection (2 arms), sponsored by Bandim Health Project. Primary endpoint: Change in cytokine level at 2 weeks compared to the baseline. Started Feb 2017; status: completed.
02
Drugs
bcg vaccine
03
Conditions
Infection
Beyond the preview
Go deeper on NCT02953327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953327.